ANVS – annovis bio, inc. (US:NASDAQ)
Stock Stats
News
4/14
11:10 am
anvs
Low
Annovis Bio (ANVS) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $17.00 price target on the stock.
4/10
08:30 am
anvs
Low
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
4/9
08:30 am
anvs
High
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
4/2
07:30 am
anvs
Medium
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
3/31
12:31 pm
anvs
Low
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Highlights Buntanetap Development in The Scientist Publication [TheStreet.com]
4/14
11:01 am
Maintains
Buy
Buy
Canaccord Genuity
Low
1.0%
4/10
06:00 am
anvs
Medium
Form 8-K Annovis Bio, Inc. For: Apr 09
4/9
05:10 pm
anvs
Medium
Form 424B5 Annovis Bio, Inc.
4/3
05:06 pm
anvs
Medium
Form 4 Annovis Bio, Inc. For: Apr 02 Filed by: Hoffman Michael B
4/2
04:39 pm
anvs
Medium
Form 144 Annovis Bio, Inc. Filed by: White Mark K.
3/25
05:19 pm
anvs
Medium
Form 8-K Annovis Bio, Inc. For: Mar 23
Show more
Top News Gainers
1/28 Annovis Bio Announces Pricing of Initial Public Offering 44.6%
4/3 Form 8-K Annovis Bio, Inc. For: Apr 03 15.0%
2/13 Annovis Bio Announces Update on Phase II Clinical Trial for Alzheimer’s Disease 10.5%
4/13 Annovis Bio to Hold Investor Webinar and Q&A Session with CEO on April 14 5.8%
4/30 Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68  Parkinson’s and Alzheimer’s Patients 5.3%
1/31 Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 3.4%
3/25 Form 10-K Annovis Bio, Inc. For: Dec 31 2.3%
4/20 Form SC 13D Annovis Bio, Inc. Filed by: Maccecchini Maria-Luisa 1.3%
4/23 Annovis Bio Publishes Results of Alzheimer’s and Parkinson’s Animal Studies 0.3%
Top News Decliners
1/30 Form 424B4 Annovis Bio, Inc. -26.7%
2/14 Form S-8 Annovis Bio, Inc. -10.3%
2/6 Form 8-K Annovis Bio, Inc. For: Jan 30 -9.3%
3/19 Annovis Bio to Present at the Online Spring Investor Summit on March 25 -7.0%
5/1 Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report -3.9%
2/20 Annovis Issued Patent for Method of Treating Parkinson’s Disease and Other Lewy Body Diseases -3.2%
2/5 Form 4 Annovis Bio, Inc. For: Jan 31 Filed by: Bruck Claudine -2.9%
4/15 Annovis up 23% after webinar on neurodegeneration candidates [Seeking Alpha] -2.6%
2/27 Annovis Awarded $1.7 Million NIH Grant for ANVS401 Chronic Toxicology Studies -0.4%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3